JDM Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.5K Sell
642
-26
-4% -$3.64K 0.03% 82
2025
Q4
$82K Buy
668
+4
+0.6% +$486 0.03% 84
2025
Q3
$73.8K Buy
664
+4
+0.6% +$455 0.03% 81
2025
Q2
$73.2K Buy
660
+4
+0.6% +$426 0.03% 73
2025
Q1
$73.5K Buy
656
+5
+0.8% +$516 0.04% 73
2024
Q4
$60.2K Sell
651
-555
-46% -$50K 0.03% 77
2024
Q3
$101K Buy
1,206
+27
+2% +$2.06K 0.06% 60
2024
Q2
$80.9K Buy
1,179
+13
+1% +$868 0.05% 61
2024
Q1
$85.4K Buy
1,166
+12
+1% +$923 0.06% 50
2023
Q4
$93.5K Buy
1,154
+10
+0.9% +$778 0.08% 50
2023
Q3
$85.7K Buy
1,144
+12
+1% +$923 0.08% 49
2023
Q2
$87.3K Buy
1,132
+11
+1% +$877 0.08% 51
2023
Q1
$93K Buy
1,121
+10
+0.9% +$828 0.09% 48
2022
Q4
$95.4K Buy
+1,111
New +$88K 0.09% 48

Other funds holding GILD

JDM Financial Group's GILD Position: Q1 2026 in Review

JDM Financial Group reduced its Gilead Sciences (GILD) stake by 3.9% in Q1 2026, selling an estimated $3.64K and leaving 642 shares worth $89.5K. The position accounts for 0.03% of the portfolio, ranked #82.

JDM Financial Group first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $101K in Q3 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • JDM Financial Group held 642 shares of Gilead Sciences worth $89.5K as of Q1 2026.
  • JDM Financial Group sold 26 Gilead Sciences shares in Q1 2026, an estimated $3.64K.
  • Gilead Sciences made up 0.03% of JDM Financial Group's portfolio in Q1 2026, its #82 holding.
  • JDM Financial Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • JDM Financial Group's Gilead Sciences position peaked at $101K in Q3 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on JDM Financial Group's 13F filing for Q1 2026, filed 21 May 2026.